Inflammatory biomarker may indicate coronary lesion

08/19/2013 | MedPage Today (free registration)

A study that used intravascular ultrasound and optical coherence tomography found the biomarker pentraxin 3 could serve as a red flag that patients are at risk of heart attack, researchers argue in JACC: Cardiovascular Interventions. Also in this article, using carotid intima-media thickness to determine vascular age and combining it with the Framingham risk score could help identify patients at risk of a severe heart attack, according to a report published in the journal Echocardiography.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC